Bioline
Meridian Bioscience Fiscal Q3 Revenues Grow 2 Percent
Meridian's Diagnostics segment grew 2 percent lifted by a 10 percent increase in revenues from the illumigene molecular product line.
NEW YORK (GenomeWeb) ― Tracking immunity and virus shedding after oral polio vaccination usually requires culture of poliovirus from stool samples.
Meridian Bio FY Q3 Sales Inch Up
NEW YORK (GenomeWeb) – Meridian Bioscience today reported a slight improvement in its fiscal third quarter sales as it missed consensus Wall Street expectations on the top and bottom lines.
Bioline, a Meridian Bioscience company, this week launched the EPIK Quantification and EPIK Amplification kits.
Sygnis said this week that Qiagen has launched the first two products of a series of kits based on Sygnis' proprietary SensiPhi amplification technology.
Nov 14, 2013
Jul 11, 2013
Feb 16, 2012
Aug 23, 2011
Jul 22, 2010
Apr 1, 2010